{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:28:32Z","timestamp":1789039712709,"version":"build-2803163510"},"reference-count":62,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173990"],"award-info":[{"award-number":["82173990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Administration of Traditional Chinese Medicine High-Level Key Discipline-Traditional Chinese Medicine Pharmacy Discipline","award":["zyyzdxk-2023272"],"award-info":[{"award-number":["zyyzdxk-2023272"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Melanoma is one of the most dangerous types of skin cancer, with its global incidence having surged in recent years. There exists an urgent clinical need for novel therapeutic strategies that combine high efficacy, low toxicity, and multiple mechanisms of action. Methods: This study applies a \u201cProperty Optimization and Therapeutic Synergy\u201d strategy, selecting the natural active polysaccharide component, Cordyceps polysaccharides (WCP), as a functional carrier to encapsulate the broad-spectrum chemotherapeutic agent, 10-Hydroxycamptothecin (10HCPT, HCPT). Leveraging non-covalent interactions between the two components, a self-assembly nanoscale drug delivery system (H-W NPs) with high stability and dual antitumor activity was constructed to achieve more efficient and precise antitumor effects. Results: The H-W NPs demonstrated outstanding antitumor efficacy both in vitro and in vivo. The H-W NPs achieved a threefold increase in the inhibition rate against B16-F10 cells compared to free HCPT in vitro and demonstrated a remarkable tumor inhibition rate of 95.08% in vivo. The therapeutic effect may be attributed to the dual antitumor mechanisms of the H-W NPs. Mechanistic studies revealed a synergistic dual-mode of action driving this potent efficacy. Firstly, H-W NPs efficiently induced caspase-3-mediated apoptosis in tumor cells. RNA sequencing analysis suggested the involvement of pathways related to cell cycle arrest and apoptosis. Additionally, H-W NPs promoted the expansion and activation of CD8+ T cells in the spleen. These activated cytotoxic T cells reinforced the apoptotic cascade, effectively amplifying the caspase-3-mediated death signal. Conclusions: In summary, the self-assembly nanoscale drug system achieved potent antitumor efficacy through the synergistic action of direct tumor cell killing and immune modulation, offering a highly promising strategy for the development of novel formulations against melanoma.<\/jats:p>","DOI":"10.3390\/pharmaceutics18030366","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:13:14Z","timestamp":1773659594000},"page":"366","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Green Self-Assembled Nanoplatform of 10-Hydroxycamptothecin and Cordyceps Polysaccharides for Dual Anti-Tumor Efficacy Through Apoptosis and Immune Modulation"],"prefix":"10.3390","volume":"18","author":[{"given":"Shu","family":"Zhou","sequence":"first","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Li","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Xv","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-7385","authenticated-orcid":false,"given":"Jie","family":"Bai","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e01388","DOI":"10.1002\/advs.202501388","article-title":"Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109324","DOI":"10.1016\/j.bioorg.2025.109324","article-title":"Ellagic acid derivatives as potential inhibitors of melanoma cell metastasis: Insights into MMP-related mechanisms","volume":"168","author":"Qatran","year":"2026","journal-title":"Bioorg. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hu, L., Wang, Y., Liu, L., and Liu, X. (2025). CD33 drives cutaneous melanoma: Mendelian randomization confirms causality, multi-omics and in vitro experiments reveal M2 macrophage polarization-mediated progression. Int. J. Surg.","DOI":"10.1097\/JS9.0000000000004100"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115204","DOI":"10.1016\/j.colsurfb.2025.115204","article-title":"Revolutionizing cancer treatment: Nanotherapeutics targeting the tumor micro-environment","volume":"258","author":"Joshi","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/17435889.2025.2592970","article-title":"Advancing melanoma treatment with nanoparticles: From chemotherapy to combination therapies","volume":"21","author":"Hsu","year":"2026","journal-title":"Nanomedicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"172472","DOI":"10.1016\/j.ejphar.2019.172472","article-title":"Alkaloids for cancer prevention and therapy: Current progress and future perspectives","volume":"858","author":"Mondal","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.2147\/IJN.S134005","article-title":"10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG(1000)-HCPT conjugate: High stabilizing efficiency and improved antitumor efficacy","volume":"12","author":"Yang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118693","DOI":"10.1016\/j.ijpharm.2019.118693","article-title":"Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity","volume":"571","author":"Cai","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/1061186X.2017.1380654","article-title":"Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: Preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics","volume":"26","author":"Zhu","year":"2018","journal-title":"J. Drug Target."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nano.2015.12.373","article-title":"In vitro and in vivo anti-tumor efficacy of 10-hydroxycamptothecin polymorphic nanoparticle dispersions: Shape- and polymorph-dependent cytotoxicity and delivery of 10-hydroxycamptothecin to cancer cells","volume":"12","author":"Wang","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Song, M., Yin, S., Zhao, R., Liu, K., Kundu, J.K., Shim, J.H., Lee, M.H., and Dong, Z. (2019). (S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity. Cancers, 11.","DOI":"10.3390\/cancers11121964"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123945","DOI":"10.1016\/j.ijpharm.2024.123945","article-title":"Formulating 10-hydroxycamptothecin into nanoemulsion with functional excipient tributyrin: An innovative strategy for targeted hepatic cancer chemotherapy","volume":"654","author":"Yang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40205","DOI":"10.1038\/s41598-025-24027-2","article-title":"Synergistic anticancer effects of carrier-free self-assembled doxorubicin and emodin nanoparticles in non-small cell lung cancer","volume":"15","author":"Tang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2018.12.003","article-title":"Hydroxycamptothecin nanoparticles based on poly\/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy","volume":"134","author":"Guo","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s43440-020-00138-7","article-title":"Drug resistance in cancer: Mechanisms and tackling strategies","volume":"72","author":"Haider","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ultras.2011.10.009","article-title":"Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system: 10-hydroxycamptothecin loaded PLA microbubbles","volume":"52","author":"Hou","year":"2012","journal-title":"Ultrasonics"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, T., Hu, Y., Yang, W., Huang, X., Zhang, L., Hou, X., Shen, P., Jian, R., Liu, Z., and Pi, J. (2025). Preparation and Antitumor Evaluation of Four Pentacyclic Triterpenoids and 10-Hydroxycamptothecin Self-Assembled Nanoparticles. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17121577"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12951-020-00679-2","article-title":"Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein\/DOX nanodispersions","volume":"18","author":"Wang","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102278","DOI":"10.1016\/j.mtbio.2025.102278","article-title":"Carrier-free nanoparticles based on natural products trigger dual \u201csynergy and attenuation\u201d for enhanced phototherapy of liver cancer","volume":"35","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kotenkova, E., Kotov, A., and Nikitin, M. (2025). Polysaccharide-Based Nanocarriers for Natural Antimicrobials: A Review. Polymers, 17.","DOI":"10.3390\/polym17131750"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/10717544.2020.1745329","article-title":"Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer","volume":"27","author":"Li","year":"2020","journal-title":"Drug Deliv."},{"key":"ref_27","first-page":"46","article-title":"Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers","volume":"1","author":"Tan","year":"2020","journal-title":"Biomater. Transl."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115286","DOI":"10.1016\/j.colsurfb.2025.115286","article-title":"Colloidal self-assembly of astilbin with smilax glabra polysaccharides enables carrier-free delivery and improved anti-inflammatory performance","volume":"259","author":"Wu","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"140394","DOI":"10.1016\/j.ijbiomac.2025.140394","article-title":"Purification, structural characterization, and in vitro immunomodulatory activity of a low-molecular-weight polysaccharide from cultivated Chinese cordyceps","volume":"301","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chen, L., Liu, X., Zheng, K., Wang, Y., Li, M., Zhang, Y., Cui, Y., Deng, S., Liu, S., and Zhang, G. (2024). Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects. Molecules, 29.","DOI":"10.3390\/molecules29215107"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ptr.70144","article-title":"An Immunomodulatory Mushroom, Cordyceps militaris, and Its Constituents: A Review of In Vitro\/In Vivo Studies and Clinical Trials","volume":"40","author":"Yang","year":"2025","journal-title":"Phytother. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129336","DOI":"10.1016\/j.ijbiomac.2024.129336","article-title":"A review on polysaccharide biosynthesis in Cordyceps militaris","volume":"260","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.actbio.2019.02.039","article-title":"A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin","volume":"88","author":"Pu","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"35488","DOI":"10.1021\/acsomega.4c11098","article-title":"The Effect of Cordyceps sinensis Polysaccharide Combined with Cisplatin on LLC1 Lung Cancer","volume":"10","author":"Wang","year":"2025","journal-title":"ACS Omega"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"129223","DOI":"10.1016\/j.foodchem.2021.129223","article-title":"Selenium release kinetics and mechanism from Cordyceps sinensis exopolysaccharide-selenium composite nanoparticles in simulated gastrointestinal conditions","volume":"350","author":"Xiao","year":"2021","journal-title":"Food Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijbiomac.2017.03.016","article-title":"Construction of a Cordyceps sinensis exopolysaccharide-conjugated selenium nanoparticles and enhancement of their antioxidant activities","volume":"99","author":"Xiao","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"137275","DOI":"10.1016\/j.ijbiomac.2024.137275","article-title":"A systematic review on polysaccharides from fermented Cordyceps sinensis: Advances in the preparation, structural characterization, bioactivities, structure-activity relationships","volume":"282","author":"Yao","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/07388551.2023.2231139","article-title":"Bioactive compounds from Cordyceps and their therapeutic potential","volume":"44","author":"Krishna","year":"2024","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/acsptsci.5c00389","article-title":"Mechanistic Modeling of Size and Surface Charge Changes of Gold and Silver Nanoparticles during In Vitro Nanoparticle Protein Corona Formation","volume":"8","author":"Chen","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13854","DOI":"10.1021\/acsnano.4c16986","article-title":"tert-Butoxycarbonyl-Modification Driven Disturbance of Molecular Ordering Enables High-Efficiency Dual Drugs Co-Assembly for Synergistic Tumor Inhibition","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-024-50819-7","article-title":"Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tan, L., Liu, S., Li, X., He, J., He, L., Li, Y., Yang, C., Li, Y., Hua, Y., and Guo, J. (2023). The Large Molecular Weight Polysaccharide from Wild Cordyceps and Its Antitumor Activity on H22 Tumor-Bearing Mice. Molecules, 28.","DOI":"10.3390\/molecules28083351"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0973-1482.131365","article-title":"Anti-cancer effects of CME-1, a novel polysaccharide, purified from the mycelia of Cordyceps sinensis against B16-F10 melanoma cells","volume":"10","author":"Jayakumar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1142\/S0192415X2550079X","article-title":"Cordycepin: A Promising Anticancer Compound from Traditional Chinese Medicine","volume":"53","author":"Li","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcis.2024.04.013","article-title":"Empowering hydrophobic anticancer drugs by ultrashort peptides: General Co-assembly strategy for improved solubility, targeted efficacy, and clinical application","volume":"667","author":"Gao","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"19295","DOI":"10.1021\/acsami.5b05347","article-title":"Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance","volume":"7","author":"Zhao","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"125747","DOI":"10.1016\/j.ijbiomac.2023.125747","article-title":"The cellular uptake of Cordyceps sinensis exopolysaccharide-selenium nanoparticles and their induced apoptosis of HepG2 cells via mitochondria- and death receptor-mediated pathways","volume":"247","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"155747","DOI":"10.1016\/j.metabol.2023.155747","article-title":"The role of ROS in tumor infiltrating immune cells and cancer immunotherapy","volume":"151","author":"Shah","year":"2024","journal-title":"Metabolism"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation\u2014Have anti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_51","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_52","first-page":"444","article-title":"Size, shape, charge and \u201cstealthy\u201d surface: Carrier properties affect the drug circulation time in vivo","volume":"16","author":"Di","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The Roles of CD8(+) T Cell Subsets in Antitumor Immunity","volume":"30","author":"Ohashi","year":"2020","journal-title":"Trends Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.2147\/IJN.S377149","article-title":"Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin","volume":"17","author":"Chen","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kreis, N.N., Louwen, F., and Yuan, J. (2019). The Multifaceted p21 (Cip1\/Waf1\/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy. Cancers, 11.","DOI":"10.3390\/cancers11091220"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7150\/jca.13614","article-title":"Tetrahydroanthraquinone Derivative (\u00b1)-4-Deoxyaustrocortilutein Induces Cell Cycle Arrest and Apoptosis in Melanoma Cells via Upregulation of p21 and p53 and Downregulation of NF-kappaB","volume":"7","author":"Genov","year":"2016","journal-title":"J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/mmr.2013.1333","article-title":"Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: Novel targets for gastric cancer","volume":"7","author":"Song","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hep.22649","article-title":"Blocking the hedgehog pathway inhibits hepatoblastoma growth","volume":"49","author":"Gruner","year":"2009","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1158\/1078-0432.CCR-07-1181","article-title":"Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma","volume":"14","author":"Tada","year":"2008","journal-title":"Clin. Cancer Res."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/3\/366\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:20:00Z","timestamp":1773660000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/3\/366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["pharmaceutics18030366"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18030366","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]}}}